Isaiah Song
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Isaiah Song has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Shinji Fukuda
Institute for Advanced Biosciences, Keio University, Tsuruoka, Japan
4 shared publications - Satoru Fukiya
Laboratory of Microbial Physiology, Research Faculty of Agriculture, Hokkaido University, Kita 9, Nishi 9, Kita-ku, Sapporo, Hokkaido 060-8589, Japan
3 shared publications - Jiayue Yang
Institute for Advanced Biosciences, Keio University, Tsuruoka, Yamagata, Japan
2 shared publications Misa Saito
Metagen, Inc., Tsuruoka, Japan
2 shared publicationsTakeshi Ichinohe
Division of Viral Infection, Department of Infectious Disease Control, International Research Center for Infectious Diseases, Institute of Medical Science, The University of Tokyo, Tokyo, Japan
2 shared publicationsTenagy Hartanto
Metagen, Inc., Tsuruoka, Japan
2 shared publications
Latest Publications
- Open Access
- 29 April 2026
- Published by Taylor & Francis in Gut Microbes Reports
- Vol. 3 (1)
Development of a monoclonal antibody-based approach for selective enrichment of target Bifidobacterium longum from a complex fecal community
A large number of microbes colonize the human gut, totaling approximately 38 trillion bacterial cells.1 Despite continuous exposure to environmental and dietary perturbations, the gut microbiota ge...
- 29 April 2026
- Published by Taylor & Francis in Gut Microbes Reports
- Vol. 3 (1)
Open AccessDevelopment of a monoclonal antibody-based approach for selective enrichment of target Bifidobacterium longum from a complex fecal community
A large number of microbes colonize the human gut, totaling approximately 38 trillion bacterial cells.1 Despite continuous exposure to environmental and dietary perturbations, the gut microbiota ge...
- 18 December 2025
- Published by Oxford University Press (OUP) in Bioscience, Biotechnology, and Biochemistry
- Vol. 90 (3) , 402-413
Identification and characterization of Dorea ammoniilytica as a novel deoxycholic acid-producing bacterial species in the human gut microbiota
Deoxycholic acid (DCA), a representative secondary bile acid, is produced by specific gut bacteria through bile acid 7α-dehydroxylation of cholic acid, catalyzed by enzymes encoded in the bai gene operon. Exploration of diversity and functional characteristics of DCA-producing bacteria is crucial for understanding the “in vivo” mechanisms of DCA production in the human intestine. Here, we have identified and characterized two strains derived from human feces as a novel DCA-producing species, Dorea ammoniilytica. These strains harbored segmented bai gene operons in their complete genome sequences and showed high DCA production activity from cholic acid in the culture experiments. Biochemical, phylogenetic, and average nucleotide identity analyses categorized them as D. ammoniilytica, which belongs to a distinct lineage from other known DCA producers and Dorea species. These findings expand the diversity of secondary bile acid-producing bacteria in the human gut microbiota and provide clues for clarifying the in vivo DCA production mechanisms.
- 18 December 2025
- Published by Oxford University Press (OUP) in Bioscience, Biotechnology, and Biochemistry
- Vol. 90 (3) , 402-413
Identification and characterization of Dorea ammoniilytica as a novel deoxycholic acid-producing bacterial species in the human gut microbiota
Deoxycholic acid (DCA), a representative secondary bile acid, is produced by specific gut bacteria through bile acid 7α-dehydroxylation of cholic acid, catalyzed by enzymes encoded in the bai gene operon. Exploration of diversity and functional characteristics of DCA-producing bacteria is crucial for understanding the “in vivo” mechanisms of DCA production in the human intestine. Here, we have identified and characterized two strains derived from human feces as a novel DCA-producing species, Dorea ammoniilytica. These strains harbored segmented bai gene operons in their complete genome sequences and showed high DCA production activity from cholic acid in the culture experiments. Biochemical, phylogenetic, and average nucleotide identity analyses categorized them as D. ammoniilytica, which belongs to a distinct lineage from other known DCA producers and Dorea species. These findings expand the diversity of secondary bile acid-producing bacteria in the human gut microbiota and provide clues for clarifying the in vivo DCA production mechanisms.
- Open Access
- 16 November 2025
- Published by Taylor & Francis in Gut Microbes Reports
- Vol. 2 (1) , 2574930
Ecologically robust gut environment associated with personalized metabolic responses in a Japanese cohort
The gut microbiota and the metabolites they synthesize are strongly associated with host physiology. Both the gut microbiota structure and the metabolites produced by the gut microbiota are involve...
- 16 November 2025
- Published by Taylor & Francis in Gut Microbes Reports
- Vol. 2 (1) , 2574930
Open AccessEcologically robust gut environment associated with personalized metabolic responses in a Japanese cohort
The gut microbiota and the metabolites they synthesize are strongly associated with host physiology. Both the gut microbiota structure and the metabolites produced by the gut microbiota are involve...
- Open Access
- 14 March 2024
- Published by Springer Nature in npj Science of Food
- Vol. 8 (1) , 1-9
Prebiotic inulin ameliorates SARS-CoV-2 infection in hamsters by modulating the gut microbiome
Current treatment options for COVID-19 are limited, with many antivirals and immunomodulators restricted to the most severe cases and preventative care limited to vaccination. As the SARS-CoV-2 virus and its increasing variants threaten to become a permanent fixture of our lives, this new reality necessitates the development of cost-effective and accessible treatment options for COVID-19. Studies have shown that there are correlations between the gut microbiome and severity of COVID-19, especially with regards to production of physiologically beneficial short-chain fatty acids (SCFAs) by gut microbes. In this study, we used a Syrian hamster model to study how dietary consumption of the prebiotic inulin affected morbidity and mortality resulting from SARS-CoV-2 infection. After two weeks of observation, we discovered that inulin supplementation attenuated morbid weight loss and increased survival rate in hamster subjects. An analysis of microbiome community structure showed significant alterations in 15 genera. Notably, there were also small increases in fecal DCA and a significant increase in serum DCA, perhaps highlighting a role for this secondary bile acid in conferring protection against SARS-CoV-2. In light of these results, inulin and other prebiotics are promising targets for future investigation as preventative treatment options for COVID-19.
- 14 March 2024
- Published by Springer Nature in npj Science of Food
- Vol. 8 (1) , 1-9
Open AccessPrebiotic inulin ameliorates SARS-CoV-2 infection in hamsters by modulating the gut microbiome
Current treatment options for COVID-19 are limited, with many antivirals and immunomodulators restricted to the most severe cases and preventative care limited to vaccination. As the SARS-CoV-2 virus and its increasing variants threaten to become a permanent fixture of our lives, this new reality necessitates the development of cost-effective and accessible treatment options for COVID-19. Studies have shown that there are correlations between the gut microbiome and severity of COVID-19, especially with regards to production of physiologically beneficial short-chain fatty acids (SCFAs) by gut microbes. In this study, we used a Syrian hamster model to study how dietary consumption of the prebiotic inulin affected morbidity and mortality resulting from SARS-CoV-2 infection. After two weeks of observation, we discovered that inulin supplementation attenuated morbid weight loss and increased survival rate in hamster subjects. An analysis of microbiome community structure showed significant alterations in 15 genera. Notably, there were also small increases in fecal DCA and a significant increase in serum DCA, perhaps highlighting a role for this secondary bile acid in conferring protection against SARS-CoV-2. In light of these results, inulin and other prebiotics are promising targets for future investigation as preventative treatment options for COVID-19.
- Open Access
- 21 September 2023
- Published by Microbiology Society in International Journal of Systematic and Evolutionary Microbiology
- Vol. 73 (9) , 006030
Claveliimonas bilis gen. nov., sp. nov., deoxycholic acid-producing bacteria isolated from human faeces, and reclassification of Sellimonas monacensis Zenner et al. 2021 as Claveliimonas monacensis comb. nov.
Obligately anaerobic, Gram-stain-positive, bacilli, strains 12BBH14T, 9CFEGH4 and 10CPCBH12, were isolated from faecal samples of healthy Japanese people. Strain 12BBH14T showed the highest 16S rRNA gene sequence similarity to Sellimonas monacensis Cla-CZ-80T (97.5 %) and ‘Lachnoclostridium phocaeense’ Marseille-P3177T (97.2 %). Strain 12BBH14T was also closely related to Eubacterium sp. c-25 with 99.7 % 16S rRNA gene sequence similarity. The 16S rRNA gene sequence analysis showed that strains 12BBH14T, 9CFEGH4 and 10CPCBH12 formed a monophyletic cluster with Eubacterium sp. c-25. Near this monophyletic cluster, S. monacensis Cla-CZ-80T and ‘L. phocaeense’ Marseille-P3177T formed a cluster and did not form a cluster with other Sellimonas species. The digital DNA–DNA hybridization (dDDH) and average nucleotide identity (ANI) values between strains 12BBH14T, 9CFEGH4, 10CPCBH12 and Eubacterium sp. c-25 were higher than the cut-off values of species demarcation (>88 % dDDH and >98 % ANI), indicating that these four strains are the same species. On the other hand, the dDDH and ANI values of these strains were lower than the cut-off values of species demarcation against other strains (<29 % dDDH and <76 % ANI). Moreover, the average amino acid identity values among these strains were higher than the genus boundary. These results indicate that the isolates should be considered to belong to a new genus of the family Lachnospiraceae . Based on the collected data, strains 12BBH14T, 9CFEGH4 and 10CPCBH12 represent a novel species of a novel genus, for which the name Claveliimonas bilis gen. nov., sp. nov. is proposed. The type strain of C. bilis is 12BBH14T (=JCM 35899T=DSM 115701T). Eubacterium sp. c-25 belongs to C. bilis. In addition, S. monacensis is transferred to the genus Claveliimonas as Claveliimonas monacensis comb. nov.
- 21 September 2023
- Published by Microbiology Society in International Journal of Systematic and Evolutionary Microbiology
- Vol. 73 (9) , 006030
Open AccessClaveliimonas bilis gen. nov., sp. nov., deoxycholic acid-producing bacteria isolated from human faeces, and reclassification of Sellimonas monacensis Zenner et al. 2021 as Claveliimonas monacensis comb. nov.
Obligately anaerobic, Gram-stain-positive, bacilli, strains 12BBH14T, 9CFEGH4 and 10CPCBH12, were isolated from faecal samples of healthy Japanese people. Strain 12BBH14T showed the highest 16S rRNA gene sequence similarity to Sellimonas monacensis Cla-CZ-80T (97.5 %) and ‘Lachnoclostridium phocaeense’ Marseille-P3177T (97.2 %). Strain 12BBH14T was also closely related to Eubacterium sp. c-25 with 99.7 % 16S rRNA gene sequence similarity. The 16S rRNA gene sequence analysis showed that strains 12BBH14T, 9CFEGH4 and 10CPCBH12 formed a monophyletic cluster with Eubacterium sp. c-25. Near this monophyletic cluster, S. monacensis Cla-CZ-80T and ‘L. phocaeense’ Marseille-P3177T formed a cluster and did not form a cluster with other Sellimonas species. The digital DNA–DNA hybridization (dDDH) and average nucleotide identity (ANI) values between strains 12BBH14T, 9CFEGH4, 10CPCBH12 and Eubacterium sp. c-25 were higher than the cut-off values of species demarcation (>88 % dDDH and >98 % ANI), indicating that these four strains are the same species. On the other hand, the dDDH and ANI values of these strains were lower than the cut-off values of species demarcation against other strains (<29 % dDDH and <76 % ANI). Moreover, the average amino acid identity values among these strains were higher than the genus boundary. These results indicate that the isolates should be considered to belong to a new genus of the family Lachnospiraceae . Based on the collected data, strains 12BBH14T, 9CFEGH4 and 10CPCBH12 represent a novel species of a novel genus, for which the name Claveliimonas bilis gen. nov., sp. nov. is proposed. The type strain of C. bilis is 12BBH14T (=JCM 35899T=DSM 115701T). Eubacterium sp. c-25 belongs to C. bilis. In addition, S. monacensis is transferred to the genus Claveliimonas as Claveliimonas monacensis comb. nov.
- Open Access
- 7 August 2023
- Published by Springer Nature in Research Square
Prebiotic inulin ameliorates SARS-CoV-2 infection by modulating the gut microbiome and increasing DCA formation in a Syrian hamster model
Current treatment options for COVID-19 are limited, with many antivirals and immunomodulators restricted to the most severe cases and preventative care limited to vaccination. As the SARS-CoV-2 virus and its increasing variants threaten to become a permanent fixture of our lives, this new reality necessitates the development of cost-effective and accessible treatment options for COVID-19. Studies have shown that there are correlations between the gut microbiome and severity of COVID-19, especially with regards to production of physiologically beneficial short-chain fatty acids (SCFAs) by gut microbes. In this study, we used a Syrian hamster model to study how dietary consumption of the prebiotic inulin affected morbidity and mortality resulting from SARS-CoV-2 infection. After two weeks of observation, we discovered that inulin supplementation attenuated morbid weight loss and increased survival rate in hamster subjects. An analysis of microbiome community structure showed significant alterations in 15 genera. Notably, there were also small increases in fecal DCA and a significant increase in serum DCA, perhaps highlighting a role for this secondary bile acid in conferring protection against SARS-CoV-2. In light of these results, inulin and other prebiotics are promising targets for future investigation as preventative treatment options for COVID-19.
- 7 August 2023
- Published by Springer Nature in Research Square
Open AccessPrebiotic inulin ameliorates SARS-CoV-2 infection by modulating the gut microbiome and increasing DCA formation in a Syrian hamster model
Current treatment options for COVID-19 are limited, with many antivirals and immunomodulators restricted to the most severe cases and preventative care limited to vaccination. As the SARS-CoV-2 virus and its increasing variants threaten to become a permanent fixture of our lives, this new reality necessitates the development of cost-effective and accessible treatment options for COVID-19. Studies have shown that there are correlations between the gut microbiome and severity of COVID-19, especially with regards to production of physiologically beneficial short-chain fatty acids (SCFAs) by gut microbes. In this study, we used a Syrian hamster model to study how dietary consumption of the prebiotic inulin affected morbidity and mortality resulting from SARS-CoV-2 infection. After two weeks of observation, we discovered that inulin supplementation attenuated morbid weight loss and increased survival rate in hamster subjects. An analysis of microbiome community structure showed significant alterations in 15 genera. Notably, there were also small increases in fecal DCA and a significant increase in serum DCA, perhaps highlighting a role for this secondary bile acid in conferring protection against SARS-CoV-2. In light of these results, inulin and other prebiotics are promising targets for future investigation as preventative treatment options for COVID-19.
- Open Access
- 29 October 2021
- Published by MDPI AG in Microorganisms
- Vol. 9 (11) , 2254
Comparative Genomic and Physiological Analysis against Clostridium scindens Reveals Eubacterium sp. c-25 as an Atypical Deoxycholic Acid Producer of the Human Gut Microbiota
The human gut houses bile acid 7α-dehydroxylating bacteria that produce secondary bile acids such as deoxycholic acid (DCA) from host-derived bile acids through enzymes encoded by the bai operon. While recent metagenomic studies suggest that these bacteria are highly diverse and abundant, very few DCA producers have been identified. Here, we investigated the physiology and determined the complete genome sequence of Eubacterium sp. c-25, a DCA producer that was isolated from human feces in the 1980s. Culture experiments showed a preference for neutral to slightly alkaline pH in both growth and DCA production. Genomic analyses revealed that c-25 is phylogenetically distinct from known DCA producers and possesses a multi-cluster arrangement of predicted bile-acid inducible (bai) genes that is considerably different from the typical bai operon structure. This arrangement is also found in other intestinal bacterial species, possibly indicative of unconfirmed 7α-dehydroxylation capabilities. Functionality of the predicted bai genes was supported by the induced expression of baiB, baiCD, and baiH in the presence of cholic acid substrate. Taken together, Eubacterium sp. c-25 is an atypical DCA producer with a novel bai gene cluster structure that may represent an unexplored genotype of DCA producers in the human gut.
- 29 October 2021
- Published by MDPI AG in Microorganisms
- Vol. 9 (11) , 2254
Open AccessComparative Genomic and Physiological Analysis against Clostridium scindens Reveals Eubacterium sp. c-25 as an Atypical Deoxycholic Acid Producer of the Human Gut Microbiota
The human gut houses bile acid 7α-dehydroxylating bacteria that produce secondary bile acids such as deoxycholic acid (DCA) from host-derived bile acids through enzymes encoded by the bai operon. While recent metagenomic studies suggest that these bacteria are highly diverse and abundant, very few DCA producers have been identified. Here, we investigated the physiology and determined the complete genome sequence of Eubacterium sp. c-25, a DCA producer that was isolated from human feces in the 1980s. Culture experiments showed a preference for neutral to slightly alkaline pH in both growth and DCA production. Genomic analyses revealed that c-25 is phylogenetically distinct from known DCA producers and possesses a multi-cluster arrangement of predicted bile-acid inducible (bai) genes that is considerably different from the typical bai operon structure. This arrangement is also found in other intestinal bacterial species, possibly indicative of unconfirmed 7α-dehydroxylation capabilities. Functionality of the predicted bai genes was supported by the induced expression of baiB, baiCD, and baiH in the presence of cholic acid substrate. Taken together, Eubacterium sp. c-25 is an atypical DCA producer with a novel bai gene cluster structure that may represent an unexplored genotype of DCA producers in the human gut.